Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides
Kimon V. Argyropoulos(Memorial Sloan Kettering Cancer Center), Marina P. Siakantaris(National and Kapodistrian University of Athens), Penelope Korkolopoulou(National and Kapodistrian University of Athens), M. Lia Palomba(Memorial Sloan Kettering Cancer Center), Maria K. Angelopoulou(Laiko General Hospital of Athens), Constantin N. Baxevanis(National and Kapodistrian University of Athens), Sonia A. Perez(Florida International University), Melissa Pulitzer(Memorial Sloan Kettering Cancer Center)
Cited by 16
Related Papers
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
|New England Journal of Medicine|2015|937
Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium
|Brain Pathology|2008|479
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
|The Lancet|2021|456
Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium
|Acta Neuropathologica|2009|329